Skip to content

Neuropace, Inc. NPCE Accrued and Employee-related Liabilities, Current

Accrued and Employee-related Liabilities, Current at other companies

Rayonier logo
RayonierRYN
$39.17M+510%
TaskUs logo
TaskUsTASK
$8.18M+17.4%
Pegasystems logo
PegasystemsPEGA
$67.22M+20.2%
TopBuild Corporation logo
TopBuild CorporationBLD
$251.99M+30.2%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$25.79M+55.3%
Ceva logo
CevaCEVA
$7.43M

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept npce:AccruedAndEmployeeRelatedLiabilitiesCurrent.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s accrued and employee-related liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s accrued and employee-related liabilities, current?
Neuropace, Inc. (NPCE) reported accrued and employee-related liabilities, current of $9.34M in Q1 2026.
How has Neuropace, Inc.'s accrued and employee-related liabilities, current changed year-over-year?
Neuropace, Inc.'s accrued and employee-related liabilities, current increased by 16.0% year-over-year, from $8.06M to $9.34M.
What is the long-term trend for Neuropace, Inc.'s accrued and employee-related liabilities, current?
Over 5 years (2020 to 2025), Neuropace, Inc.'s accrued and employee-related liabilities, current has grown at a 15.1% compound annual growth rate (CAGR), from $6.6M to $13.34M.
What does accrued and employee-related liabilities, current mean?
This includes short-term obligations for employee compensation, benefits, bonuses, and payroll taxes that have been earned but not yet disbursed. It provides visibility into the company's immediate human capital costs and the timing of payroll-related cash outflows. Monitoring this helps assess the company's commitment to its workforce and its short-term liquidity requirements.